Yesterday PPMD invited Sarepta leaders to join a community discussion regarding the New Drug Application for golodirsen. We apologize if you were unable to access the webinar audio due to the high number of attendees. We look forward to learning more about next steps as Sarepta and the FDA work to bring our community a safe, effective therapy.

Watch the recording: